首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Metabolism-clinical and experimental

缩写:METABOLISM

ISSN:0026-0495

e-ISSN:1532-8600

IF/分区:11.9/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3335
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yan Han,Jing Tang,Na Wu et al. Yan Han et al.
Background: The association between Life's Essential 8 (LE8) score and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) remains unknown. ...
Qi Wu,Yan Zeng,Kang Geng et al. Qi Wu et al.
Diabetic cardiomyopathy (DCM) is the primary cause of heart failure in patients with diabetes and is characterised by contractile dysfunction and left ventricular hypertrophy. The complex pathological and physiological mechanisms underlying...
Zachary A Kipp,Olufunto O Badmus,David E Stec et al. Zachary A Kipp et al.
The rising rates of obesity worldwide have increased the incidence of cardiovascular disease (CVD), making it the number one cause of death. Higher plasma bilirubin levels have been shown to prevent metabolic dysfunction and CVD. However, r...
Angelo Armandi,Chiara Rosso,Gian Paolo Caviglia et al. Angelo Armandi et al.
Hepatocellular carcinoma (HCC) is a relevant complication occurring in individuals with advanced Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD). Recent epidemiological data suggest an alarming increase in the HCC burden wo...
Konstantinos Stefanakis,Geltrude Mingrone,Jacob George et al. Konstantinos Stefanakis et al.
Background: There are no known non-invasive tests (NITs) designed for accurately detecting metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis stages F2-F3, excluding cirrhosis-the FDA-defined rang...
Fernando Bril,Alicia Elbert Fernando Bril
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a systemic disease characterized by insulin resistance and lipotoxicity. Its association with type 2 diabetes, cardiovascular disease, liver cirrhosis, and hepatocellular c...
Amir Ajoolabady,Domenico Pratico,Mohsen Mazidi et al. Amir Ajoolabady et al.
PCSK9 is a serine protease that regulates plasma levels of low-density lipoprotein (LDL) and cholesterol by mediating the endolysosomal degradation of LDL receptor (LDLR) in the liver. When PCSK9 functions unchecked, it leads to increased d...